Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.02 USD | -0.79% | -0.79% | -10.67% |
15/03 | Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. | CI |
13/03 | Craig-Hallum Downgrades Champions Oncology to Hold From Buy | MT |
Sales 2024 * | 48.84M 4.07B | Sales 2025 * | 53.68M 4.48B | Capitalization | 68.24M 5.69B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.4 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.27 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.79% |
Latest transcript on Champions Oncology, Inc.
1 day | -0.79% | ||
1 week | -0.79% | ||
Current month | +2.45% | ||
3 months | -19.74% | ||
6 months | -17.30% | ||
Current year | -10.67% |
Managers | Title | Age | Since |
---|---|---|---|
Ronnie Morris
CEO | Chief Executive Officer | 58 | 26/10/26 |
Brady Davis
PSD | President | - | 17/23/17 |
Joel Ackerman
CHM | Chairman | 59 | 26/10/26 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
FOU | Founder | 64 | 01/08/01 |
Scott Tobin
BRD | Director/Board Member | 53 | 27/11/27 |
Joel Ackerman
CHM | Chairman | 59 | 26/10/26 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 5.02 | -0.79% | 1,620 |
25/24/25 | 5.06 | +0.60% | 1,477 |
24/24/24 | 5.03 | -0.79% | 1,377 |
23/24/23 | 5.07 | +0.20% | 2,321 |
19/24/19 | 5.06 | -0.10% | 960 |
Delayed Quote Nasdaq, April 27, 2024 at 02:00 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
-10.67% | 68.24M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- CSBR Stock